Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia

Factors associated with dropout at 2 years post-initiation of treatment in the first episode of schizophrenia

Background:Prevention of new episodes during the first 2 years after a first episode of schizophrenia (FES) may delay treatment refractoriness and brain morphological changes over time. However, adherence to treatment is characteristically poor in these patients. Aim: The aim of this study was to ex...

Full description

Bibliographic Details
Main Authors:	Jebril M. Benelmokhtar, Bonginkosi Chiliza, Lebogang Phahladira, Robin Emsley, Laila Asmal
Format:	Article
Language:	English
Published:	AOSIS 2021-03-01
Series:	South African Journal of Psychiatry
Subjects:	adherence schizophrenia first episode dual diagnosis flupenthixol decanoate long acting injectable positive and negative syndrome scale
Online Access:	https://sajp.org.za/index.php/sajp/article/view/1657

Similar Items

Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
by: Francois-Pierre Joubert, et al.
Published: (2021-01-01)

Augmentation of aripiprazole by flupenthixol decanoate in poorly responsive schizophrenia: a randomized clinical study
by: Saeed Shoja Shafti
Published: (2017-07-01)

Sexual dysfunction in first-episode schizophrenia spectrum disorders
by: Hilmar Klaus Luckhoff, et al.
Published: (2022-12-01)

Barriers to long‐acting injectable atypical antipsychotic use in Japan: Insights from a comparative psychiatrist survey
by: Yoshiyo Oguchi, et al.
Published: (2024-06-01)

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
by: Gloria Giordano, et al.
Published: (2020-01-01)

Delphi panel to obtain clinical consensus about using long-acting injectable antipsychotics to treat first-episode and early-phase schizophrenia: treatment goals and approaches to functional recovery
by: Celso Arango, et al.
Published: (2023-06-01)

Symptoms at onset in first episode schizophrenia: Caregivers perspectives
by: Hema Tharoor, et al.
Published: (2015-01-01)

Oral versus long-acting injectable antipsychotic in first episode schizophrenia: A 12 weeks interventional study
by: Ramandeep Kaur, et al.
Published: (2023-04-01)

Associations of premorbid adjustment with type and timing of childhood trauma in first-episode schizophrenia spectrum disorders
by: Anna M. Smit, et al.
Published: (2021-06-01)

Instruments measuring blunted affect in schizophrenia: a systematic review.
by: Sanja Kilian, et al.
Published: (2015-01-01)

Executive attention impairment in first-episode schizophrenia
by: Orellana Gricel, et al.
Published: (2012-09-01)

Abnormal patterns of regional homogeneity and functional connectivity across the adolescent first-episode, adult first-episode and adult chronic schizophrenia
by: Yongfeng Yang, et al.
Published: (2022-01-01)

Relationship between illness disability in patients with first-episode schizophrenia with caregivers' perception of their needs
by: Ragul Ganesh, et al.
Published: (2019-01-01)

Clinical Validity of Subjective Clinical Prognosis in First Episode Psychosis Schizophrenia Patients: An Analysis of Data from the European First Episode Schizophrenia Trial (EUFEST) Study
by: Matei VP, et al.
Published: (2020-05-01)

Medication adherence in schizophrenia: Role of opinion makers
by: Ramandeep Kaur, et al.
Published: (2023-01-01)

Relationships between abnormal neural activities and cognitive impairments in patients with drug-naive first-episode schizophrenia
by: Wei Yan, et al.
Published: (2020-06-01)

The Effect of Longer Dosing Intervals for Long-Acting Injectable Antipsychotics on Outcomes in Schizophrenia
by: Milz R, et al.
Published: (2023-03-01)

Erratum: Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate
by: Francois-Pierre Joubert, et al.
Published: (2021-12-01)

First episode-psychosis: Short- and long-term outcomes and related features predicting the transition to schizophrenia
by: M. Jabeur, et al.
Published: (2022-06-01)

Double burden of malnutrition amongst patients with first-episode schizophrenia in a psychiatric hospital: A 1-year follow-up study
by: Justus U. Onu, et al.
Published: (2020-11-01)

Risk factors for relapse in patients with first-episode schizophrenia: Analysis of the Health Insurance Review and Assessment Service data from 2011 to 2015
by: Sang-Uk Lee, et al.
Published: (2018-03-01)

Differential of Frequency and Duration Mismatch Negativity and Theta Power Deficits in First-Episode and Chronic Schizophrenia
by: Yan-Bing Xiong, et al.
Published: (2019-03-01)

Prodromal phase and first episode psychosis in schizophrenia: early signs and diagnosis
by: A.-G. Buciuc, et al.
Published: (2022-06-01)

Suicidal ideation and quality of life in patients with a first episode of schizophrenia
by: Krystyna Górna, et al.
Published: (2010-03-01)

Characteristics of delayed and timely treatment seekers for first-episode schizophrenia in Thailand
by: Patcharapim Takizawa, et al.
Published: (2020-12-01)

Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study
by: Xiaoe Lang, et al.
Published: (2023-07-01)

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?
by: Zhang Cheng, et al.
Published: (2020-06-01)

Effect of prior beliefs and cognitive deficits on learning in first-episode schizophrenia patients
by: Daniel Núñez, et al.
Published: (2024-12-01)

Decreased Plasma Levels of Kynurenine and Kynurenic Acid in Previously Treated and First-Episode Antipsychotic-Naive Schizophrenia Patients
by: Miloš Marković, et al.
Published: (2023-12-01)

Telepsychiatry care during the COVID-19 outbreak in young adults with a first episode of psychosis or entering schizophrenia
by: E. Kiesmann, et al.
Published: (2021-04-01)

Quality of life and its predictors in first-episode schizophrenia and individuals at clinical high-risk for psychosis
by: Zhen Mao, et al.
Published: (2023-10-01)

Abnormalities of Electroencephalography Microstates in Drug-Naïve, First-Episode Schizophrenia
by: Qiaoling Sun, et al.
Published: (2022-03-01)

Exploring a lay Gestalt of schizophrenia? A Danish background population’s explanations on why and how first-episode schizophrenia patients’ narratives were intuitively sensed as contextually inappropriate
by: Charlotte Petersen
Published: (2017-10-01)

Prevalence of neurocognitive deficits in patients with first-episode schizophrenia in an African sample and its relationship with dimensions of psychopathology and psychosocial outcome
by: Onyekachi Kingsley Ugwuonye, et al.
Published: (2024-12-01)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
by: Sugawara N, et al.
Published: (2019-01-01)

Relationship between levels of novel inflammatory indicators and aggressivity in patients with first-episode and recurrent schizophrenia
by: Cui Ying'ao, et al.
Published: (2025-02-01)

Amygdalar and Hippocampal Morphometry Abnormalities in First-Episode Schizophrenia Using Deformation-Based Shape Analysis
by: Xiaoying Tang, et al.
Published: (2020-07-01)

Association between unmet needs and clinical status in patients with first episode of schizophrenia in Chile
by: Natalia eJorquera, et al.
Published: (2015-04-01)

Quality of life in patients with the first-episode psychosis
by: A. Usova, et al.
Published: (2021-04-01)

Comparison of Hematological Parameters Between First-Episode Schizophrenia and Anti-NMDAR Encephalitis
by: Kai Huang, et al.
Published: (2022-07-01)